What You Should Know:
- Mission Bio raises $70 million in Series C funding led by
Novo Growth to accelerate the development of cancer therapies with single-cell multi-omics.
- Mission Bio’s Tapestri Platform, the first single-cell platform capable of detecting DNA and protein changes simultaneously, gives a profound insight into the mutations that drive disease to accelerate the development of novel treatments and save patient lives.
Mission Bio,
Inc., a South San Francisco,
Read More
Clinical Trials | News, Analysis, Insights - HIT Consultant
FDA, Syapse Expand Research to Generate Real-World Data Related to COVID-19 and Cancer
What You Should Know:
The FDA and Syapse announce research collaboration expansion
to address urgent public health challenges including supporting FDA’s goal of
rapid understanding of COVID-19.
As part of the research, Syapse is partnering with FDA’s
Oncology Center of Excellence to investigate methods to derive RWD from
multiple sources including electronic health records, registries and molecular
data
Syapse, a real-world
evidence company accelerating the delivery of precision
Read More
AstraZeneca, Eko Collaborate to Advance Innovation Around Heart Failure
What You Should Know:
- Eko today announced a global collaboration with
AstraZeneca to accelerate the development of digital health tools for the
earlier screening of cardiovascular diseases, including heart failure.
- Through the collaboration, AstraZeneca and Eko will explore accelerating the development of Eko algorithms, enhancing clinical trials with Eko technology, and potentially building new heart failure detection solutions.
Eko, a digital health company
Read More
Ciox Health Acquires Biomedical NLP Company Medal
What You Should Know:
- Ciox Health has acquired Medal, Inc., a biomedical
Natural Language Processing (biomed-NLP) technology company.
- The acquisition will lead Ciox to better and more
quickly enable real-world data in support of research that advances patient
care.
Ciox
Health, a leading health technology company, today announced its acquisition
of San Francisco-based biomedical Natural Language Processing (biomed-NLP)
technology company, Medal, Inc., a leader
in
Read More
W2O Acquires Discern Health to Strengthen Value-Based Care Capabilities
What You Should Know:
- W2O announced today the acquisition of Discern Health, a leading healthcare consultancy based in Washington, DC, and Baltimore, to strengthen its strategic capabilities in assisting clients with critical healthcare policy trends and value-based reimbursement models.
- Discern Health brings experts with decades of experience in quality, health care measurement, and payment models to W2O’s analytics-driven, technology-enabled marketing and communications solutions.
Read More
COVID-19 Has Permanently Shifted Patient Behavior Towards Virtual Care
What You Should Know:
- The COVID-19 crisis has significantly impacted the
patient care paradigm, and the ripple effects have altered patient behaviors
and expectations, requiring a significant change in how life sciences companies
engage with and support patients
- Accenture surveyed 2700 patients about changes in care
during COVID-19 and found a major shift to virtual care, which patients
embraced.
- Virtual care is here to stay and can be an integral
part of the patient experience
Read More
Scripps Research, Repurpose.AI Partner to Develop COVID-19 Therapeutics
What You Should Know:
- Repurpose.AI, has partnered with Scripps Research to
discover drug candidates that may be repurposed to treat COVID-19.
- The partnership will leverage Repurpose.AI's ActivPred
AI Drug Discovery Platform, an unbiased drug, target, and disease agnostic
digital chemistry engine, to discover drug candidates to treat COVID-19.
Scripps Research is
teaming up with Repurpose.AI, an AI
drug discovery company to develop COVID-19 therapeutics. The
Read More
Kaia Health Lands $26M to Expand AI-Driven Digital Therapeutics for MSK Conditions & COPD
What You Should Know:
- Digital therapeutics company Kaia Health raises $26M in
Series B funding to help grow its digital therapy solutions for musculoskeletal
(MSK) conditions, and expand into new conditions.
- The investment was led by Optum Ventures, Idinvest and
capital300, plus participation from Balderton Capital, Heartcore Capital and
Symphony Ventures, an investment partnership with world #1 golfer Rory McIlroy.
- Kaia Health’s smartphone-based
approach to managing chronic
Read More
MD Anderson, Philips Partner on Personalized Oncology Treatments, Clinical Trial Matching
What You Should Know:
- Philips and MD Anderson collaborate to facilitate
personalized oncology treatments and clinical trial matching based on genomic
markers.
- Philips connects oncologists and pathologists around
the world to MD Anderson’s Precision Oncology Decision Support (PODS) system of
actionable clinical information
Philips and The University of Texas MD Anderson Cancer
Center today announced a collaboration to provide oncologists with
evidence-based therapy and clinical
Read More
How A Virtual Therapist Could Help Overcome Mental Healthcare Demands in Uncertain Times
Over the last few months, our hopes and expectations for 2020 have certainly been halted. There was an air of optimism globally as we entered the New Year and a new decade, but now we have been plunged into a world of uncertainty with the spreading COVID-19 pandemic. Future unknowns, both from a human well-being perspective and an economic standpoint are starting to take a toll on many people’s mental health.
Understandably, the situation we find ourselves in is creating concern and worry and
Read More
